{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:18:59Z","timestamp":1784215139706,"version":"3.55.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2019-01059"],"award-info":[{"award-number":["2019-01059"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heart and Lung Foundation and the Stig och Gunborg Westman Foundation"},{"name":"StratNeuro"},{"name":"Strategic Research Area and CIMED, Karolinska University Hospital"},{"DOI":"10.13039\/501100003514","name":"Stockholm City Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003514","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Baxter Healthcare to Karolinska Institutet"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,21]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Therapeutic developments have contributed to markedly improved clinical outcomes in peritoneal dialysis (PD) during the 1990s and 2000s. We investigated whether recent advances in PD treatment are implemented in routine Swedish care and whether their implementation parallels improved patient outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted an observational study of 3122 patients initiating PD in Sweden from 2006 to 2015. We evaluated trends of treatment practices (medications, PD-related procedures) and outcomes [patient survival, major adverse cardiovascular events (MACEs), peritonitis, transfer to haemodialysis (HD) and kidney transplantation] and analysed associations of changes of treatment practices with changes in outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Over the 10-year period, demographics (mean age 63 years, 33% women) and comorbidities remained essentially stable. There were changes in clinical characteristics (body mass index and diastolic blood pressure increased), prescribed drugs (calcium channel blockers, non-calcium phosphate binders and cinacalcet increased and the use of renin\u2013angiotensin system inhibitors, erythropoietin and iron decreased) and dialysis treatment (increased use of automated PD, icodextrin and assisted PD). The standardized 1- and 2-year mortality and MACE risk did not change over the period. Compared with the general population, the risk of 1-year mortality was 4.1 times higher in 2006\u20132007 and remained stable throughout follow-up. However, the standardized 1- and 2-year peritonitis rate decreased and the incidence of kidney transplantation increased while transfers to HD did not change.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Over the last decade, treatment advances in PD patients were accompanied by a substantial decline in peritonitis frequency and an increased rate of kidney transplantations, while 1- and 2-year survival and MACE risk did not change.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfab130","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T19:13:57Z","timestamp":1625512437000},"page":"2539-2547","source":"Crossref","is-referenced-by-count":5,"title":["Treatment practices and outcomes in incident peritoneal dialysis patients: the Swedish Renal Registry 2006\u20132015"],"prefix":"10.1093","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7266-3431","authenticated-orcid":false,"given":"Hong","family":"Xu","sequence":"first","affiliation":[{"name":"Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Lindholm","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine and Baxter Novum, Department of Clinical Sciences Intervention and Technology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika Hahn","family":"Lundstr\u00f6m","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine and Baxter Novum, Department of Clinical Sciences Intervention and Technology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Heimb\u00fcrger","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine and Baxter Novum, Department of Clinical Sciences Intervention and Technology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stendahl","sequence":"additional","affiliation":[{"name":"Swedish Renal Registry, Department of Internal Medicine, Ryhov Regional Hospital, J\u00f6nk\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Rydell","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine and Baxter Novum, Department of Clinical Sciences Intervention and Technology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5rten","family":"Segelmark","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Clinical Sciences, Lund University and Skane University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-2024","authenticated-orcid":false,"given":"Juan-Jesus","family":"Carrero","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8650-5795","authenticated-orcid":false,"given":"Marie","family":"Evans","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine and Baxter Novum, Department of Clinical Sciences Intervention and Technology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"issue":"Suppl 1","key":"2021122112471150700_sfab130-B1","first-page":"Svi","article-title":"US Renal Data System 2019 Annual Data Report: epidemiology of kidney disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2021122112471150700_sfab130-B2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","article-title":"Mortality in kidney disease patients treated with phosphate binders: a randomized study","volume":"7","author":"Di Iorio","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021122112471150700_sfab130-B3","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"EVOLVE Trial Investigators; Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"2021122112471150700_sfab130-B4","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122112471150700_sfab130-B5","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/ndt\/gfq336","article-title":"Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Study","volume":"25","author":"Locatelli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2021122112471150700_sfab130-B6","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1681\/ASN.2016010112","article-title":"The current state of peritoneal dialysis","volume":"27","author":"Mehrotra","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2021122112471150700_sfab130-B7","first-page":"CD007554","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","volume":"10","author":"Htay","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2021122112471150700_sfab130-B8","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/ndt\/gft050","article-title":"Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials","volume":"28","author":"Cho","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2021122112471150700_sfab130-B9","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1053\/j.ajkd.2013.11.025","article-title":"Comparative outcomes between continuous ambulatory and automated peritoneal dialysis: a narrative review","volume":"63","author":"Bieber","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2021122112471150700_sfab130-B10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/sdi.12571","article-title":"Innovations in treatment delivery, risk of peritonitis, and patient retention on peritoneal dialysis","volume":"30","author":"Piraino","year":"2017","journal-title":"Semin Dial"},{"key":"2021122112471150700_sfab130-B11","doi-asserted-by":"crossref","first-page":"e0206600","DOI":"10.1371\/journal.pone.0206600","article-title":"Telemonitoring system for patients with chronic kidney disease undergoing peritoneal dialysis: usability assessment based on a case study","volume":"13","author":"Mart\u00ednez Garc\u00eda","year":"2018","journal-title":"PLoS One"},{"key":"2021122112471150700_sfab130-B12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s40620-020-00812-2","article-title":"Remote monitoring in peritoneal dialysis: benefits on clinical outcomes and on quality of life","volume":"33","author":"Milan Manani","year":"2020","journal-title":"J Nephrol"},{"key":"2021122112471150700_sfab130-B13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.ajkd.2011.01.024","article-title":"Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population","volume":"58","author":"Roberts","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2021122112471150700_sfab130-B14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ndt\/gfv295","article-title":"Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period","volume":"31","author":"van de Luijtgaarden","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2021122112471150700_sfab130-B15","author":"Svenskt Njurregister (Swedish Renal Registry)"},{"key":"2021122112471150700_sfab130-B16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"2021122112471150700_sfab130-B17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/1536867X1201200408","article-title":"A command to calculate age-standardized rates with efficient interval estimation","volume":"12","author":"Consonni","year":"2012","journal-title":"Stata J"},{"key":"2021122112471150700_sfab130-B18","doi-asserted-by":"crossref","first-page":"e90119","DOI":"10.1371\/journal.pone.0090119","article-title":"Relative survival of peritoneal dialysis and haemodialysis patients: effect of cohort and mode of dialysis initiation","volume":"9","author":"Heaf","year":"2014","journal-title":"PLoS One"},{"key":"2021122112471150700_sfab130-B19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrneph.2016.181","article-title":"Changes in the worldwide epidemiology of peritoneal dialysis","volume":"13","author":"Li","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2021122112471150700_sfab130-B20","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/ndt\/gfaa357","article-title":"Association between implementation of novel therapies and improved survival in patients starting hemodialysis: the Swedish Renal Registry 2006\u20132015","volume":"36","author":"Evans","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2021122112471150700_sfab130-B21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.kint.2020.01.046","article-title":"Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"97","author":"Flythe","year":"2020","journal-title":"Kidney Int"},{"key":"2021122112471150700_sfab130-B22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.jrn.2018.05.006","article-title":"Overview of the 2017 KDIGO CKD-MBD update: practice implications for adult hemodialysis patients","volume":"29","author":"Beto","year":"2019","journal-title":"J Ren Nutr"},{"key":"2021122112471150700_sfab130-B23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"2021122112471150700_sfab130-B24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/089686080902900503","article-title":"Peritoneal dialysis in Brazil: twenty-five years of experience in a single center","volume":"29","author":"Moraes","year":"2009","journal-title":"Perit Dial Int"},{"key":"2021122112471150700_sfab130-B25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/089686080702700411","article-title":"Improving outcome of CAPD: twenty-five years\u2019 experience in a single Korean center","volume":"27","author":"Han","year":"2007","journal-title":"Perit Dial Int"},{"key":"2021122112471150700_sfab130-B26","first-page":"1","volume-title":"ANZDATA 2013 Annual Report","author":"Boudville","year":"2013"},{"key":"2021122112471150700_sfab130-B27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.ajkd.2014.02.025","article-title":"Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes","volume":"64","author":"Cho","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2021122112471150700_sfab130-B28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/089686089901900311","article-title":"A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis","volume":"19","author":"Rodr\u00edguez-Carmona","year":"1999","journal-title":"Perit Dial Int"},{"key":"2021122112471150700_sfab130-B29","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2215\/CJN.00910209","article-title":"Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database","volume":"4","author":"Nessim","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfab130\/40408272\/sfab130.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/14\/12\/2539\/41837957\/sfab130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/14\/12\/2539\/41837957\/sfab130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T12:48:46Z","timestamp":1640090926000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/14\/12\/2539\/6318396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,7,9]]},"published-print":{"date-parts":[[2021,12,21]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfab130","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12]]},"published":{"date-parts":[[2021,7,9]]}}}